Literature DB >> 22478827

Payers Try New Approaches To Manage Molecular Diagnostics: Some payers require prior authorization for molecular diagnostic testing and some don't. And some payers are looking at other options.

.   

Abstract

Year:  2010        PMID： 22478827      PMCID： PMC2957737     

Source DB:  PubMed          Journal:  Biotechnol Healthc        ISSN： 1554-169X


× No keyword cloud information.
  4 in total

1.  Seeking a Coding Solution For Molecular Tests: Managing the estimated 1,700 molecular tests now on the market is impossible without a unique CPT code for each test. What's at stake? The future of personalized medicine.

Authors:  Bob Carlson
Journal:  Biotechnol Healthc       Date:  2010

2.  Gene expression profile testing for breast cancer and the use of chemotherapy, serious adverse effects, and costs of care.

Authors:  Jennifer S Haas; Su-Ying Liang; Michael J Hassett; Stephen Shiboski; Elena B Elkin; Kathryn A Phillips
Journal:  Breast Cancer Res Treat       Date:  2011-06-17       Impact factor: 4.872

3.  Clinical integration of next generation sequencing: coverage and reimbursement challenges.

Authors:  Patricia A Deverka; Jennifer C Dreyfus
Journal:  J Law Med Ethics       Date:  2014       Impact factor: 1.718

4.  The need for clinical decision support integrated with the electronic health record for the clinical application of whole genome sequencing information.

Authors:  Brandon M Welch; Kensaku Kawamoto
Journal:  J Pers Med       Date:  2013-12-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.